Literature DB >> 2530872

Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160.

R A Chahine1, R L Feldman, T D Giles, A E Raizner, R J Weiss, P Nicod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2530872     DOI： 10.1016/0002-8703(89)90842-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

1.  Amlodipine has a preventive effect on temporal left ventricular hypokinesia after emotional stress compared with an angiotensin II receptor blocker.

Authors:  Fuminobu Ishikura; Yuri Takano; Takashi Ueyama
Journal:  J Med Ultrason (2001)       Date:  2012-09-06       Impact factor: 1.314

Review 2.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Antianginal effects of amlodipine at a single dose on exertional angina patients using treadmill exercise testing--a randomized crossover study in comparison with placebo.

Authors:  H Kishida; N Hata; T Kunimi; H Miyagawa; H Nishiyama; K Katoh
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

4.  Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.

Authors:  P Santarelli; F Biscione; A Natale; A Manzoli; G A Lanza
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

5.  Efficacy of amlodipine besilate therapy for variant angina: evaluation by 24-hour Holter monitoring.

Authors:  K Watanabe; T Izumi; Y Miyakita; S Koyama; M Ohshima; T Inomata; M Suzuki; M Takahashi; A Shibata
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.